首页 | 本学科首页   官方微博 | 高级检索  
检索        

基于网络药理学和分子对接法探寻清宣止咳颗粒治疗儿童新型冠状病毒肺炎活性化合物
引用本文:宗阳,姚卫峰,单进军,汪受传.基于网络药理学和分子对接法探寻清宣止咳颗粒治疗儿童新型冠状病毒肺炎活性化合物[J].世界中医药,2020,15(4):477-483.
作者姓名:宗阳  姚卫峰  单进军  汪受传
作者单位:南京中医药大学附属苏州市中医医院,苏州,215009;苏州市吴门医派研究院,苏州,215009;南京中医药大学药学院,南京,210023;江苏省儿童呼吸疾病(中医药)重点实验室,南京中医药大学,南京,210023
基金项目:国家自然科学基金项目(81973445,81573554);江苏省“六大人才高峰”高层次人才项目(YY026);苏州市“科教兴卫”青年课题(KJXW2019044);苏州市科技局指导性课题(SYSD2019149);苏州市中医医院院级科技计划项目(YQN2017004)
摘    要:目的:探寻清宣止咳颗粒治疗儿童新型冠状病毒肺炎(COVID-19)的活性化合物。方法:借助中药系统药理学分析平台(TCMSP)检索清宣止咳颗粒中桑叶、薄荷、苦杏仁、桔梗、白芍、枳壳,陈皮、紫菀、甘草的化学成分和作用靶点。通过UniProt、GeneCards等数据库查询靶点对应的基因,进而运用Cytoscape 3.7.2构建化合物-靶点(基因)网络,通过DAVID进行基因本体(GO)功能富集分析和基于京都基因与基因组百科全书(KEGG)通路富集分析,预测其作用机制。结果:化合物-靶点网络包含141个化合物和相应靶点292个,关键靶点涉及PTGS2、ESR1、HSP90AA1、CALM1、AR等。GO功能富集分析得到GO条目339个(P<0.05),其中生物过程(BP)条目244个,细胞组成(CC)条目33个,分子功能(MF)条目62个。KEGG通路富集筛选得到96条信号通路(P<0.05),涉及小细胞肺癌、非小细胞肺癌、T细胞受体信号通路等。分子对接结果显示槲皮素、山柰酚、木犀草素等核心化合物与新冠病毒的亲和力与推荐用药相似。结论:清宣止咳颗粒中的有效活性成分可能通过作用于PTGS2、HSP90AA1、ESR1等靶点调节多条信号通路从而抑制新型冠状病毒肺炎作用。

关 键 词:清宣止咳颗粒  新型冠状病毒肺炎  网络药理学  分子对接  槲皮素  山柰酚  木犀草素
收稿时间:2020/2/24 0:00:00

Discussion on the Active Compounds of Qingxuan Zhike Granule in Treatment of Pediatric Coronavirus Disease 2019 Based on Network Pharmacology and Molecular Docking Method
ZONG Yang,YAO Weifeng,SHAN Jinjun,WANG Shouchuan.Discussion on the Active Compounds of Qingxuan Zhike Granule in Treatment of Pediatric Coronavirus Disease 2019 Based on Network Pharmacology and Molecular Docking Method[J].World Chinese Medicine,2020,15(4):477-483.
Authors:ZONG Yang  YAO Weifeng  SHAN Jinjun  WANG Shouchuan
Institution:1 Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine,Suzhou 215009,China; 2 Suzhou Academy of Wumen Medical School,Suzhou 215009,China; 3 School of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China; 4 Key Laboratory of Pediatric Respiratory Diseases (TCM),Nanjing University of Chinese Medicine,Nanjing 210023,China
Abstract:To explore the active compounds of Qingxuan Zhike Granule for treatment of pediatric Coronavirus disease 2019 (COVID-19).Methods:With the help of the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP),the chemical constituents and action targets of mulberry leaf,peppermint,bitter apricot seed,platycodon root,debark peony root,orange fruit,dried tangerine peel,tatarian aster root,liquorice root in Qingxuan Zhike granules were retrieved.The genes corresponding to the target were queried through databases such as UniProt and GeneCards,and then Cytoscape 3.7.2 was used to build a compound-target (gene) network,gene ontology (GO) function enrichment analysis was perform through DAVID,based on the Kyoto Encyclopedia of Genes and Genomes (KEGG ) Path enrichment analysis,its mechanism was predicted.Results:The compound-target network contains 141 compounds and 292 corresponding targets.The key targets are PTGS2,ESR1,HSP90AA1,CALM1,AR,etc.GO function enrichment analysis obtained 339 GO entries (P<0.05),of which 244 were biological process (BP) entries,33 were cell composition (CC) entries,and 62 were molecular function (MF) entries.The KEGG Path enrichment analysis obtained 96 signal pathways (P<0.05),involving small cell lung cancer,non-small cell lung cancer,and T cell receptor signaling pathways.The molecular docking results showed that the core compounds such as quercetin,Kaempferol,luteolin and the like had similar affinity to the COVID-19 virus as the recommended drugs.Conclusion:The active ingredients in Qingxuan Zhike granules may regulate multiple signaling pathways by acting on targets such as PTGS2,HSP90AA1,and ESR1,thereby inhibiting COVID-19.
Keywords:Qingxuan Zhike granules  Coronavirus disease 2019  Network pharmacology  Molecular docking  Quercetin  Kaempferol  Luteolin
本文献已被 维普 万方数据 等数据库收录!
点击此处可从《世界中医药》浏览原始摘要信息
点击此处可从《世界中医药》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号